behavior/neurological
• attenuated response to morphine withdrawal
|
• failure to decrease locomotor activity following administration of kappa-opioid agonist
|
• increased threshold response to abdominal constriction test
• failure to raise threshold response in hot plate and tail immersion tests after administration of kappa-opioid agonist
|
endocrine/exocrine glands
• failure to salivate after administration of kappa-opioid agonist
|
reproductive system
digestive/alimentary system
• failure to salivate after administration of kappa-opioid agonist
|
homeostasis/metabolism
• failure to salivate after administration of kappa-opioid agonist
|